The Ensign Group, Inc. (NASDAQ:ENSG) had its price target boosted by Cantor Fitzgerald from $23.00 to $27.00 in a report released on Thursday. The brokerage currently has an overweight rating on the stock.
“Adjusting outlook. We are trimming our 2017 EPS estimate to $1.42 from $1.45, but are raising our 2018 estimate to $1.65 from $1.60 to reflect stronger recent revenue growth in ENSG’s core skilled nursing business, as well as its ancillary businesses.”,” the firm’s analyst wrote.
A number of other analysts have also weighed in on ENSG. BidaskClub lowered shares of The Ensign Group from a strong-buy rating to a buy rating in a research report on Monday, July 31st. Zacks Investment Research lowered shares of The Ensign Group from a hold rating to a sell rating in a research report on Tuesday, August 8th. TheStreet raised shares of The Ensign Group from a c+ rating to a b rating in a research report on Monday, August 7th. Finally, Royal Bank Of Canada reissued a buy rating and issued a $21.00 price objective on shares of The Ensign Group in a research report on Tuesday, November 7th. Three investment analysts have rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company. The company currently has a consensus rating of Hold and a consensus target price of $23.00.
The Ensign Group (NASDAQ:ENSG) traded down $0.04 during trading on Thursday, reaching $23.20. 121,800 shares of the company were exchanged, compared to its average volume of 155,041. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.53 and a quick ratio of 1.58. The Ensign Group has a 12 month low of $16.50 and a 12 month high of $23.96. The stock has a market cap of $1,187.17, a price-to-earnings ratio of 19.66 and a beta of 0.84.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, October 31st. Investors of record on Saturday, September 30th were given a $0.043 dividend. This represents a $0.17 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date of this dividend was Thursday, September 28th. The Ensign Group’s dividend payout ratio (DPR) is currently 18.89%.
In other news, Director Antoinette T. Hubenette sold 2,500 shares of the firm’s stock in a transaction that occurred on Tuesday, September 12th. The shares were sold at an average price of $20.95, for a total transaction of $52,375.00. Following the transaction, the director now directly owns 24,626 shares of the company’s stock, valued at $515,914.70. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Over the last ninety days, insiders have sold 3,566 shares of company stock worth $75,957. Corporate insiders own 6.20% of the company’s stock.
Large investors have recently modified their holdings of the company. Riverhead Capital Management LLC increased its position in shares of The Ensign Group by 86.6% during the second quarter. Riverhead Capital Management LLC now owns 4,664 shares of the company’s stock worth $102,000 after acquiring an additional 2,164 shares during the period. SG Americas Securities LLC purchased a new position in shares of The Ensign Group during the third quarter worth approximately $104,000. UBS Group AG increased its position in shares of The Ensign Group by 93.9% during the first quarter. UBS Group AG now owns 6,986 shares of the company’s stock worth $131,000 after acquiring an additional 3,383 shares during the period. Oppenheimer Asset Management Inc. purchased a new position in shares of The Ensign Group during the first quarter worth approximately $131,000. Finally, Pinebridge Investments L.P. increased its position in shares of The Ensign Group by 0.6% during the second quarter. Pinebridge Investments L.P. now owns 6,280 shares of the company’s stock worth $137,000 after acquiring an additional 38 shares during the period. 84.06% of the stock is currently owned by institutional investors and hedge funds.
The Ensign Group Company Profile
The Ensign Group, Inc, through its operating subsidiaries, provides healthcare services across the post-acute care continuum, as well as other ancillary businesses located in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Texas, Utah, Washington and Wisconsin.
Receive News & Ratings for The Ensign Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.